Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

SHPL0000371_036 - Absence of antibodies to AIDS virus in haemophiliacs treated with heat treated factor VIII concentrate - 02 Feb 1985.pdf [pdf]

Published on: 30 June, 2023

WITN1775001 Written statement of Matthew ANON.pdf [pdf]

Published on: 24 April, 2020

SHPL0000293_142 - Memo from Ron Feakes to Patrick Rafferty - 01 Jun 1990.pdf [pdf]

Published on: 30 June, 2023

SHPL0000276_106 - Letter from J Brazer to Department of Health and Social Security - 26 Aug 1977.pdf [pdf]

Published on: 30 June, 2023

SHPL0000279_012 - Hyland Division Travenol Laboratories guidance for Donor Requirements Check List - 30 Apr 1976.pdf [pdf]

Published on: 30 June, 2023

SHPL0000085_037 - Letter from Immuno Ltd to Dr Eibl and Dr Schwarz and Dr Anderle and Mrs Diernhofer - 27 Sep 1983.pdf [pdf]

Published on: 30 June, 2023

SHPL0000078_011 - Feiba Medical Assessment - 10 Jun 1985.pdf [pdf]

Published on: 30 June, 2023

SHPL0000279_018 - Hyland Division Travenol Laboratories guidance for Whole blood and plasma processing log - 18 Jan 1977.pdf [pdf]

Published on: 30 June, 2023

SHPL0000106_150 - FEIBA TIM 4 IMMUNO Anti-Inhibitor-Coagulant Complex Steam Treated - 01 Jul 1989.pdf [pdf]

Published on: 30 June, 2023

SHPL0000275_029 - Application for a product licence for Hemofil.pdf [pdf]

Published on: 30 June, 2023

SHPL0000276_167 - Letter from S Nathoo to B L Steer - 22 Mar 1973.pdf [pdf]

Published on: 30 June, 2023

SHPL0000276_181 - Letter from M C Lort to Travenol Laboratories - 12 Oct 1972.pdf [pdf]

Published on: 30 June, 2023

WITN1776001 Written statement of [W1776].pdf [pdf]

Published on: 24 April, 2020

SHPL0000071_066 - Fax from Mr Berry to Mrs Sperr - 09 Nov 1973.pdf [pdf]

Published on: 30 June, 2023

SHPL0000275_013 - Antihemophilic factor Human Method Four - 01 Jun 1971.pdf [pdf]

Published on: 30 June, 2023

SHPL0000071_155 - Letter from Unknown to Doctor Eibl - 04 Jul 1973.pdf [pdf]

Published on: 30 June, 2023

SHPL0000091_007 - Feiba Immuno.pdf [pdf]

Published on: 30 June, 2023

SHPL0000141_233 - Letter from from R Nicholson to Mrs Henninger - 30 Oct 1986.pdf [pdf]

Published on: 30 June, 2023

SHPL0000104_017 - Letter from Norman Berry to K Attwood - 29 Oct 1984.pdf [pdf]

Published on: 30 June, 2023

SHPL0000086_055 - Report on Feiba Immuno Factor VIII Inhibitor bypassing fraction human - 28 Jan 1977.pdf [pdf]

Published on: 30 June, 2023

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 484
  • Page 485
  • Page 486
  • Page 487
  • Current page 488
  • Page 489
  • Page 490
  • Page 491
  • Page 492
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.